We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Bereskin & Parr LLP

Offices

  1. Canada

    1. Kitchener ON

      101 Frederick Street Suite 1004, Kitchener ON N2H 6R2, Canada T 1 519 783 3210 F 1 519 783 3211
    2. Mississauga ON

      Manulife Corporate Park, 6733 Mississauga Road, Suite 600, Mississauga ON L5N 6J5, Canada T 1 905 812 3600 F 1 905 814 0031
    3. Montreal QC

      600 Boulevard De Maisonneuve Ouest, Bureau 2800, Montreal QC H3A 3J2, Canada T 1 514 868 0203 F 1 514 868 0208
    4. Toronto ON

      Scotia Plaza, 40 King Street West, 40th Floor, Toronto ON M5H 3Y2, Canada T 1 416 364 7311 F 1 416 361 1398
  1. Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

    Canada - May 16 2013

    The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

  2. Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

    Canada - May 9 2013

    The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

  3. Online brand protection strategies: new gTLDs and the Trademark Clearinghouse

    Global - April 30 2013

    ICANN received over 1,900 applications for new Generic Top-Level Domains (“gTLDs”) and it is estimated that at least 500 will launch, with the first

  4. Retailers’ challenge of the OQLF’s interpretation of the Charter of the French Language

    Canada - April 30 2013

    On October 9, 2012, six retailers, BEST BUY, Costco, GAP, OLD NAVY, GUESS? And WAL-MART, filed a motion in the Superior Court of Quebec seeking a

  5. THALOMID is not an innovative drug eligible for Canadian data protection

    Canada - March 4 2013

    In Canada, drugs that are classified as "Innovative drugs" are eligible for eight years of data protection (data exclusivity). In April 2012, the

  1. Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

    Canada - May 16 2013

    The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

  2. Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

    Canada - May 9 2013

    The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

  3. Getting ready for the launch of new gTLDs - the Trademark Clearinghouse is open

    Global - April 30 2013

    ICANN's new Generic Top-Level Domain ("gTLD") program has been forging ahead, and it is expected that about 500 new gTLD applications will launch

  4. Retailers’ challenge of the OQLF’s interpretation of the Charter of the French Language

    Canada - April 30 2013

    On October 9, 2012, six retailers, BEST BUY, Costco, GAP, OLD NAVY, GUESS? And WAL-MART, filed a motion in the Superior Court of Quebec seeking a

  5. Online brand protection strategies: new gTLDs and the Trademark Clearinghouse

    Global - April 30 2013

    ICANN received over 1,900 applications for new Generic Top-Level Domains (“gTLDs”) and it is estimated that at least 500 will launch, with the first